SCHEMBL23382800

SCHEMBL23382800

CCC(C)(C)OC(=O)Oc1ccc(C(=O)OCC(F)(F)C(=O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 3/20 0.43
▸ TDP1 Q9NUW8 2/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ SCN1A P35498 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ SCN5A Q14524 1/20 0.37
▸ SCN2A Q99250 1/20 0.37
▸ SCN3A Q9NY46 1/20 0.37
▸ STS P08842 3/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ MAPT P10636 4/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ PDK1 Q15118 1/20 0.35
▸ PDK2 Q15119 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23382803 0.89 ELANE (0.56) ELANETDP1HTR1ACYP2D6SCN1A
SCHEMBL23382495 0.87 CYP2D6 (0.42) TDP1HTR1ACYP2D6SCN1ASLC6A3
SCHEMBL23382685 0.85 SMN1; SMN2 (0.44) TDP1HTR1ACYP2D6SCN1ASLC6A3
SCHEMBL23382799 0.83 TDP1 (0.42) ELANETDP1HTR1ACYP2D6SCN1A
SCHEMBL23382754 0.81 ELANE (0.43) ELANETDP1CYP2D6HPGDTP53
SCHEMBL23382802 0.81 ELANE (0.39) ELANETDP1HTR1ACYP2D6SCN1A
SCHEMBL23382801 0.80 ELANE (0.38) ELANESCN1ASCN2ASCN3ASTS
SCHEMBL23382693 0.80 SMN1; SMN2 (0.44) TDP1HTR1ACYP2D6SCN1ASLC6A3
SCHEMBL23382690 0.78 TP53 (0.47) TDP1HTR1ACYP2D6SCN1ASLC6A3
SCHEMBL23382489 0.77 MAPK1 (0.45) TDP1HTR1ACYP2D6SCN1ASLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 ELANE 2435/4885TDP1 4190/4885HTR1A 4571/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 ELANE 2435/4885TDP1 4190/4885HTR1A 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback